Skip to main content
Erschienen in: BMC Women's Health 1/2021

Open Access 01.12.2021 | Case report

Adenomyoepithelioma of the breast with prominent cystic changes: a case report

verfasst von: Feng Chen, Hengping Wu, Yujian Liu, Minli Lv, Jianquan Zhong

Erschienen in: BMC Women's Health | Ausgabe 1/2021

Abstract

Background

Adenomyoepithelioma (AME) of the breast is a rare subtype of breast tumor. Most of AMEs reported are solid, however, cystic or prominent cystic changes are extremely rare.

Case presentation

A 51-year-old woman presented a lump in the upper outer quadrant of right breast, and it was accompanied by continuous breast pain and bilateral axillary itching for more than 2 months. There were no other symptoms found. Preoperative mammography and ultrasound examination were performed. Mammography showed a noncalcified lobulated mass, and it was considered to be a benign cyst with septum on ultrasound, but ductal carcinoma of breast, adenoid cystic carcinoma could not be excluded. At first, AME was not considered preoperatively, because the imaging features of this rare tumor may vary widely, which may result in an incorrect diagnosis. But eventually, AME was diagnosed by postoperative pathology and immunohistochemistry.

Conclusion

We herein present a rare case of breast AME with prominent cystic changes. AME has no-specific imaging features, but the benign or malignant nature of the lesion might be suspected on imaging.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Adenomyoepithelioma (AME) of the breast was first described by Hamperl in 1970 [1]. According to the World Health Organization classification of breast tumors in 2012, AME was classified as epithelial-myoepithelial lesions [2]. AME is generally a benign breast tumor displaying proliferation of epithelial and myoepithelial cells, mainly myoepithelial hyperplasia. Tavasoli [3] subdivided AMEs into three variants, arranged in spindle cell type, tubules, and lobules. The diagnosis of AME was established by histopathology and immunohistochemistry. Most of AMEs showed solid mass rather than cystic mass [4], cystic or prominent cystic changes is extremely rare, in spite of a few may contain small cystic areas [5].

Case presentation

A 51-year-old woman presented a lump in the upper outer quadrant of right breast, and it was accompanied by continuous breast pain and bilateral axillary itching for more than 2 months. There were no other symptoms found. Previously she didn't undergo any breast cancer screening, and had no family history of breast cancer. Physical examination revealed an irregular mass by palpation where was 3.5 cm away from the nipple, about 11 o 'clock in the right breast, with hard texture, clear boundary, mobility and mild tenderness. Doppler ultrasound (Fig. 1a, b) showed no echogenic and irregular mass in the right breast, with solid striped septum, and weak echogenic deposition in the dorsal side, and the mass was well circumscribed. There was no blood flow signal in the lesion. Mammography (Fig. 1c, d) showed a lobed mass with slightly higher density in the right breast, smooth edge, partially concealed boundary, and there was no calcification in the mass. It was classified as category 4A by BI-RADS assessment. It was considered to be a benign cyst with septum on ultrasound, but ductal carcinoma of breast, adenoid cystic carcinoma could not be excluded. We suggested the patient undergo MRI examination, but the patient refused. Since breast cancer could not be excluded, the patient was urged for a partial mastectomy. Postoperative general features: A 3.5 cm × 3 cm × 2.2 cm mass was observed at 11 o 'clock of the right breast, 3.0 cm from the nipple, with an unclear boundary and enveloped, also a 2.8 cm maximum diameter cyst was observed on the section, and a 2.2 cm × 1.8 cm × 1.5 cm gray-white neoplasm was observed inside the cyst. Micrographs of histological specimens with HE staining (Fig. 2a) showed the mass was biphasic appearance.The outer myoepithelial cells were single or multilaye, the cytoplasm was clear and the nuclei was not atypia. The inner layer were glandular epithelial cells, arranged in an adenoid structure, with abundant cytoplasm and no nuclear atypia. And immunohistochemistry (Fig. 2b–d) showed that: CK 5/6 (+, myoepithelial), P63 (+), calponin (+, myoepithelial), CK (+), CK7 (+, epithelial), L-CK (+, epithelial), SMA (−), H-caldesmon (−), so it was diagnosed as AME. Because of the pathology and immunohistochemistry showed the tumor was well differentiated, she did not receice any further treatment after the surgery.

Discussion and conclusions

Breast AMEs are rare neoplasms. They have been described in patients ranging in age from 22 to 93 years [6], although most of them were elderly women, male cases were also reported [7]. AMEs are generally benign neoplasms, although a small number of malignant lesions have been reported in the literature, either the epithelial or myoepithelial component may undergo malignant transformation [8]. Some papers have concluded that AMEs over 2 cm should be treated as malignant [9]. Most of AMEs were solid, prominent cystic features of this tumor was extremely rare, in spite of rare minute cysts were described in a few cases of AMEs. A review of the literature indicates that only one case of cystic AME has been reported [10]. In our case, the patient had a large lesion with persistent breast pain. Although the lesions had prominent cystic changes, the boundary of some lesions was unclear, and she did not receive any further treatment after the surgery. It is important for the surgeon to achieve a clear margin when removing the tumor, because local recurrence or even malignant transformation can happen. So the patient still needed to be followed up to observe if malignant transformation occur after local lesion resection. Up to now, the patient has been followed up for half a year without recurrence or discomfort, and re-examination of ultrasound showed no abnormality. The radiological findings of breast AME are nonspecific. On ultrasound, AME typically presents as a solid, hypoechoic, small, irregular, or oval mass, often accompanied by posterior acoustic enhancement. Peripheral vascular enlargement has some features, and the mass may have catheter dilation [11, 12]. Mammography is usually characterized by a noncalcified ovoid or lobulated mass with smooth margins [13, 14]. MRI can provide additional information on the morphological and haemodynamic characteristics. On MRI, benign AMEs manifest as homogeneous signal on different sequences with Type I or II enhancement curves, while malignant AMEs presented as irregular and coarse-edged masses with type III enhanced curve [12, 15]. In our case, ultrasonography showed a lobulated mass with prominent cystic changes in the right breast, which was significantly different from the stereotypical AME images. Mammography shows a noncalcified lobulated mass, which is not significantly different from the common AME imaging findings due to the poor performance of the cystic changes on mammography. The prominent cystic features of the present tumor was easily misdiagnosed, so it’s needed to be distinguished from ductal carcinoma of breast, adenoid cystic carcinoma, lobulated tumor, cyst of galactostasia, metaplasia carcinoma, etc. The imaging findings of these tumors did not differ significantly.
AME of breast is a rare and mostly benign tumor. AME has no-specific imaging features, but the benign or malignant nature of the lesion might be suspected on imaging.

Acknowledgements

Not applicable.

Declarations

Not applicable.
The patient signed informed consent for the publication of this case report and any associated images. A copy of the consent form is available for review by the Editor of this journal.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Hamperl H. The myothelia (myoepithelial cells). Normal state; regressive changes; hyperplasia; tumors. Curr Top Pathol. 1970;53:161–220.CrossRef Hamperl H. The myothelia (myoepithelial cells). Normal state; regressive changes; hyperplasia; tumors. Curr Top Pathol. 1970;53:161–220.CrossRef
2.
Zurück zum Zitat Lakhani SR, Schnitt SJ, Tan PH, Vijver MJ. WHO Classification of Tumors of the Breast. World Health Organization Classification of Tumours. 2012. Lakhani SR, Schnitt SJ, Tan PH, Vijver MJ. WHO Classification of Tumors of the Breast. World Health Organization Classification of Tumours. 2012.
3.
Zurück zum Zitat Tavassoli FA. Myoepithelial lesions of the breast: myoepitheliosis, adenomyoepithelioma, and myoepithelial carcinoma. Am J Surg Pathol. 1991;15:554–68.CrossRef Tavassoli FA. Myoepithelial lesions of the breast: myoepitheliosis, adenomyoepithelioma, and myoepithelial carcinoma. Am J Surg Pathol. 1991;15:554–68.CrossRef
4.
Zurück zum Zitat Rosen PP. Adenomyoepithelioma of the breast. Hum Pathol. 1987;18:1232–7.CrossRef Rosen PP. Adenomyoepithelioma of the breast. Hum Pathol. 1987;18:1232–7.CrossRef
5.
Zurück zum Zitat Kim MJ, Kim CS, Ju MJ, Park YS. Malignant adenomyoepithelioma of the breast: a rare case report. Int J Surg Case Rep. 2019;59:111–4.CrossRef Kim MJ, Kim CS, Ju MJ, Park YS. Malignant adenomyoepithelioma of the breast: a rare case report. Int J Surg Case Rep. 2019;59:111–4.CrossRef
6.
Zurück zum Zitat Antonelli MS, Mallel G, Pecoraro A, Vitale V, Maggi S, Lombardi A, Stanzani G, Amanti C. Adenomyoepithelioma of the breast: case report and literature review. G Chir. 2018;39:255–7. Antonelli MS, Mallel G, Pecoraro A, Vitale V, Maggi S, Lombardi A, Stanzani G, Amanti C. Adenomyoepithelioma of the breast: case report and literature review. G Chir. 2018;39:255–7.
7.
Zurück zum Zitat Gafton B, Scripcariu V, Prutianu I, Alexa-Stratulat T, Terinte C, Nicolau A, Moisiuc D, Radu I. Challenges in management of male breast adenomioepithelioma with malignant behavior: case report. Medicine (Baltimore). 2019;98:e17587.CrossRef Gafton B, Scripcariu V, Prutianu I, Alexa-Stratulat T, Terinte C, Nicolau A, Moisiuc D, Radu I. Challenges in management of male breast adenomioepithelioma with malignant behavior: case report. Medicine (Baltimore). 2019;98:e17587.CrossRef
8.
Zurück zum Zitat Kakkar A, Jangra K, Kumar N, Sharma MC, Mathur SR, Deo SV. Epithelial-myoepithelial carcinoma of the breast: a rare type of malignant adenomyoepithelioma. Breast J. 2019;25:1273–5.CrossRef Kakkar A, Jangra K, Kumar N, Sharma MC, Mathur SR, Deo SV. Epithelial-myoepithelial carcinoma of the breast: a rare type of malignant adenomyoepithelioma. Breast J. 2019;25:1273–5.CrossRef
9.
Zurück zum Zitat Korolczuk A, Amarowicz M, Bąk K, Korobowicz E, Koncewicz T. Adenomyoepithelioma of the breast with late pulmonary metastases—case report and review of the literature. J Cardiothorac Surg. 2016;11:121.CrossRef Korolczuk A, Amarowicz M, Bąk K, Korobowicz E, Koncewicz T. Adenomyoepithelioma of the breast with late pulmonary metastases—case report and review of the literature. J Cardiothorac Surg. 2016;11:121.CrossRef
10.
Zurück zum Zitat Papaevangelou A, Pougouras I, Liapi G, Pierrakakis S, Tibishrani M, Setakis N. Cystic adenomyoepithelioma of the breast. Breast. 2004;13:356–8.CrossRef Papaevangelou A, Pougouras I, Liapi G, Pierrakakis S, Tibishrani M, Setakis N. Cystic adenomyoepithelioma of the breast. Breast. 2004;13:356–8.CrossRef
11.
Zurück zum Zitat Lee JH, Kim SH, Kang BJ, Lee AW, Song BJ. Ultrasonographic features of benign adenomyoepithelioma of the breast. Korean J Radiol. 2010;11:522–7.CrossRef Lee JH, Kim SH, Kang BJ, Lee AW, Song BJ. Ultrasonographic features of benign adenomyoepithelioma of the breast. Korean J Radiol. 2010;11:522–7.CrossRef
12.
Zurück zum Zitat Park YM, Park JS, Jung HS, Yoon HK, Yang WT. Imaging features of benign adenomyoepithelioma of the breast. J Clin Ultrasound. 2013;41:218–23.CrossRef Park YM, Park JS, Jung HS, Yoon HK, Yang WT. Imaging features of benign adenomyoepithelioma of the breast. J Clin Ultrasound. 2013;41:218–23.CrossRef
13.
Zurück zum Zitat Adejolu M, Wu Y, Santiago L, Yang WT. Adenomyoepithelial tumors of the breast: imaging findings with histopathologic correlation. AJR Am J Roentgenol. 2011;197:184–90.CrossRef Adejolu M, Wu Y, Santiago L, Yang WT. Adenomyoepithelial tumors of the breast: imaging findings with histopathologic correlation. AJR Am J Roentgenol. 2011;197:184–90.CrossRef
14.
Zurück zum Zitat Moritz AW, Wiedenhoefer JF, Profit AP, Jagirdar J. Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast malignancies: a case series emphasizing histologic, radiologic, and clinical correlation. Breast. 2016;29:132–9.CrossRef Moritz AW, Wiedenhoefer JF, Profit AP, Jagirdar J. Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast malignancies: a case series emphasizing histologic, radiologic, and clinical correlation. Breast. 2016;29:132–9.CrossRef
15.
Zurück zum Zitat Zhang L, Qin G, He Z, Chen W, Yang L. The mammography and MRI manifestations of adenomyoepithelioma of the breast. Clin Radiol. 2016;71:235–43.CrossRef Zhang L, Qin G, He Z, Chen W, Yang L. The mammography and MRI manifestations of adenomyoepithelioma of the breast. Clin Radiol. 2016;71:235–43.CrossRef
Metadaten
Titel
Adenomyoepithelioma of the breast with prominent cystic changes: a case report
verfasst von
Feng Chen
Hengping Wu
Yujian Liu
Minli Lv
Jianquan Zhong
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Women's Health / Ausgabe 1/2021
Elektronische ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-021-01432-z

Weitere Artikel der Ausgabe 1/2021

BMC Women's Health 1/2021 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.